Tudor Investment Corp
ALXO icon

Tudor Investment Corp’s ALX Oncology ALXO Stock Holding History

Tudor Investment Corp’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,098
Closed -$60.9K – 2668
2024
Q2 		$60.9K Sell
10,098
-10,142
-50% -$125K ﹤0.01% 2223
2024
Q1 		$226K Buy
+20,240
New +$284K ﹤0.01% 1986
2023
Q2 		– Sell
-20,131
Closed -$91K – 2388
2023
Q1 		$91K Buy
+20,131
New +$153K ﹤0.01% 2265

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tudor Investment Corp's ALXO Position: Q3 2024 in Review

Tudor Investment Corp sold out of ALX Oncology (ALXO) in Q3 2024, closing a stake of 10,098 shares — an estimated $60.9K sold.

Tudor Investment Corp first reported a position in ALXO in Q1 2023 and held it in 3 quarters. The position peaked at $226K in Q1 2024. 92 funds tracked by Wall St. Rank hold ALXO as of Q3 2024.

  • Tudor Investment Corp reported no remaining ALX Oncology position as of Q3 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 10,098 ALX Oncology shares in Q3 2024, an estimated $60.9K.
  • Tudor Investment Corp first reported a position in ALX Oncology in Q1 2023 and held it in 3 quarters.
  • Tudor Investment Corp's ALX Oncology position peaked at $226K in Q1 2024.
  • 92 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2024.

Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.